阳光肺科

 找回密码
 立即注册

微信扫码登录

搜索

中国肥胖药、癌症药,会成下一波全球爆款?《经济学人》分析中美医药合作为何逆势升温

[复制链接]
中国肥胖药、癌症药,会成下一波全球爆款?《经济学人》分析中美医药合作为何逆势升温
https://youtu.be/z_K4tsqw3xg?si=Jl_sKtR4LPt1WkA7
China's technological development, much like the development of human civilization, has entered a phase of accelerated growth. Three years ago, China's pharmaceutical licensing fees—meaning high-tech biopharmaceuticals—were almost zero. Last year, they reached over $40 billion, and by 2025, they are projected to reach $110 billion. Another example is the automobile industry, a pillar of Western industry, which is almost doubling in size every year, with exports expected to reach ten million vehicles by 2025. If North America hadn't banned Chinese exports, the entire automotive industry would have gone bankrupt.


回复

使用道具 举报

给我们建议|手机版|阳光肺科 ( 粤ICP备2020077405号-1 )

GMT+8, 2025-12-3 09:21

Powered by Discuz! X3.5

© 2001-2025 Discuz! Team.

快速回复 返回顶部 返回列表